The Switzerland-based company, which specializes in the development of flavours, fragrances and active cosmetic ingredients, strengthens its capabilities in bio-engineering technologies with the acquisition of French company Alderys.

Founded in 2009, Alderys is headquartered in Orsay, France. The company develops innovative approaches to the biological engineering of molecules and compounds from renewable feedstock for the chemical and cosmetic industry sectors as well as nutrition. “They are recognised for offering innovative technological industrial solutions with high sustainability standards,” highlights Givaudan in a release.

Givaudan is particularly interested in Alderys strong track record in designing innovative biological pathways to produce environmentally-friendly raw materials that will complete the group’s offer of natural cosmetic ingredients.

Alderys employs 30 people and will be integrated into Givaudan Active Beauty, Givaudan’s entity in charge of developing innovative active cosmetic ingredients with the group Fragrance Division.

The acquisition of Alderys aligns with our long term strategy for Active Beauty and more specifically, their expertise in biotechnology is fully complementary to our Fragrance and Active Beauty businesses. It will allow us to expand our portfolio of natural and biosourced products, thanks to their strong research and development bio-engineering platform. It will be an additional tool to drive our future development and innovation in the active cosmetic ingredients space and beyond. It will also reinforce Givaudan’s capabilities to support our customers in developing sustainable, performant and safe products,” said Maurizio Volpi, President of Givaudan’s Fragrance Division.

While terms of the deal have not been disclosed, Alderys’ business would have represented EUR 3 million of incremental revenues to Givaudan’s results in 2019 on a proforma basis. The planned acquisition remains subject to formal approvals from the relevant regulatory authorities and the transaction is expected to close in the second quarter of 2020.